Skip to content
Flyover Future
  • Newsletters and More
  • Podcast
  • Innovation Radar
  • Subscribe!

Diagnostic innovation | Deal Tank in Ann Arbor | Pittsburgh’s xBridge

March 18, 2021

“A correct diagnosis is three-fourths the remedy." — Mahatma Gandhi

 

Today’s itinerary:

  • Diagnostic innovation
  • Event: 2021 Future of Work Summit
  • Deal Tank in Ann Arbor
  • Pittsburgh's xBridge
  • Restoring ancient artifacts
  • Clinical treatments for obesity
  • Discover Louisville startups
  • Fueling the Future
  • Name that Flyover City!

March 18, 2021

Image
Alternate text

A CHAT WITH AN INNOVATOR

Diagnostics is about prevention

Sundaresh Brahmasandra, VP, NeoMoDx, a Qiagen company

 

Ann Arbor-based NeuMoDx™ Molecular Systems (a QIAGEN company) has been awarded the Startup Innovator Award by the National Venture Capital Association (NVCA). NeuMoDx is a family of scalable platforms that fully integrate the entire molecular diagnostic process from “sample to result.” Flyover Future spoke with Sundaresh Brahmasandra, NeuMoDx’s VP, and head of AA operations and product development about the tech behind what they do.

 

Tell us about the company?

 

Brahmasandra: We develop a molecular diagnostic platform. By that I mean we develop instruments that enable very rapid testing of real-time PCR-based diagnostics. To go along with the instruments, to power it essentially, we develop customized microfluidic cartridges that help process all of the liquids and the samples. They’re like fancy test tubes.

 

We also make all of the chemicals and reagents required to run these tests. In a sense, NeuMoDx is basically an integrated company that provides complete molecular diagnostic solutions. Of course, like many molecular diagnostic companies last year, we started working on COVID-based testing solutions in February of 2020, as soon as it was pretty apparent that this was not your usual flu.

 

We were one of the first companies to obtain emergency use authorization. From that time on, it’s been incredible from a business perspective and from employee satisfaction and everything else, because now we are for once, as a diagnostic company, we are actually part of a great solution to the problem we’re having.

 

Can you define for me exactly what you mean by molecular diagnostic solution?

 

Brahmasandra: In diagnostics, you’re either looking for the DNA or the RNA piece of the infectious agent, or you’re looking for some other protein or chemical that is a signature of that infection or disease status. By molecular, the most common definition is that you’re looking not necessarily at the protein or the chemicals that come later, but more at the DNA or RNA signature right at the heart of the infection or the disease state.

 

We take a swab sample, for example for COVID, and it goes into a little tube, and the user basically loads that tube directly onto the system. At that point, the system then takes over and does what it has to do.

 

In your nasal swab, there’s all sorts of stuff – your normal human cells that come from the nose, as well as the viral particles. We have to extract the RNA of this viral particle and then go through an amplification process where we may have only 10 or 100 of these particles, and it’s really hard to detect them at that point.

 

So we go through an amplification process called PCR, polymerase chain reaction, and it takes this piece of the RNA and looks for unique sections in this RNA that are unique to the COVID-19 virus, for example. If you’re designing a test for HIV, you would do the same thing and look for something that’s unique to the HIV virus. Then we multiply that particular section a billion or a trillion times so that we can now measure this amplified signal compared to the very low starting signal.

 

RNA became a topic as the CovId vaccines were being developed.

 

Brahmasandra: The vaccine is mimicking the virus. It’s putting in a piece of the RNA that makes the body think that the virus is there. All that RNA is doing is producing a protein that is usually on the surface of this virus. Instead of the virus being there, it’s just that protein there in your cells now, and that triggers your immune system to say, "Oh that protein is there, hence that virus must be there, and so it now triggers your immune system to go and attack it." That’s how those works.

"Diagnostics is about prevention, but we get about maybe three to five percent of the healthcare love."

 

— Sundaresh Brahmasandra, NeuMoDx

What is the NVCA Startup Innovator Award?

 

Brahmasandra: The NVCA is the premier venture capital association in the United States. NeuMoDx was initiated by a venture fund out of Ann Arbor called Arboretum Ventures which specializes in med-tech and devices and drugs.

 

Arboretum actually nominated us this year for this award. As part of that process, I talked to the NVCA and gave them the spiel on what we do and how we have been a critical part of the COVID solution. We were always unique and different and we were making a huge advancement in molecular diagnostics.

 

The COVID crisis obviously amplified or put a spotlight on the whole diagnostics industry. Solutions like ours, where we could run lots and lots of samples in a day, without any training required, became very important.

 

The system is unique in that it can run a lot of samples. One instrument can run up to 600 samples in a 24-hour shift. At the same time, if there was an emergency sample that came in, we could get the results for those emergency samples in 80 minutes. So it met both the needs, urgent testing for a rapid solution, or if I need lots of testing, it can be a high-volume solution. This unique proposition made it a very attractive solution, especially in the COVID time frame. So we were nominated as part of that, and that’s how we were chosen out of the field for this award.

 

COVID has affected the industry in different ways

 

Brahmasandra: Absolutely. If you look at the overall state of diagnostics providers, this has been our constant beef, right? Diagnostics is about prevention, but we get about maybe three to five percent of the healthcare love, whereas a lot of the money goes toward treatment, which is actually too far down the road sometimes.

 

If we can help prevent it up front, I think that costs can be much lower. Definitely this has highlighted the importance of having rapid tools for diagnosis. It’s unfortunate it took a pandemic to do it, but at least it’s something.

Share this story!

Facebook Twitter

FEATURED EVENT

With Louisville Future of Work

How will you gain insights using data & AI?

2021 Future of Work Summit

April 7th and 8th the Future of Work Initiative is hosting its second annual conference: Accelerating AI and Data Automation. Last year's conference had more than 1,000 influencers and decision-makers in digital technology from across the region. The event also featured national experts on digital transformation, tech talent, and the impact of the coming AI revolution. Speakers represented companies including Microsoft, UPS, Humana, GE Appliances (a Haier Company), the Brookings Institution, and more.

 

The 2021 Future of Work Summit is a must-attend event to gain insights and remain ahead of the curve when it comes to developing and implementing your AI and data automation strategies.

 

This year's conference will be entirely virtual, from 11:00am to 2:15pm April 7th and 8th and will focus on innovations across the healthcare, manufacturing, logistics, and e-commerce sectors. Speakers and panelists will be announced each week in the lead-up to the conference.

REGISTER TODAY

Share this event!

Facebook Twitter

PUDDLE HOPS

Deal Tank in Ann Arbor

Ann Arbor’s David Weaver, who co-founded CitySide Ventures, Birmingham Angels, and Great Lakes Angels, has co-created a monthly virtual Deal Tank for early-stage companies to pitch investors in Michigan and throughout the Midwest. Investors that are interested to attend will be able to still register online.

Pittsburgh's xBridge 

A 10,000-sq.ft. space at Pittsburgh’s International Airport called the xBridge is where companies can collaborate on new ideas poised to increase efficiency. The facility churns out minimal viable products much sooner than a traditional product development model.

Restoring ancient artifacts

Brent Seales, a professor at the University of Kentucky, has been awarded a grant from the National Endowment for the Humanities (NEH) to create a cultural heritage imaging and analysis laboratory. The lab will restore ancient artifacts thought to be damaged beyond repair.

Clinical treatments for obesity

A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will conduct further research into new clinical treatments for multiple obesity syndromes.

Share these stories!

Facebook Twitter
 
 

FUELING THE FUTURE

What is fueling Flyover Country innovation? In this weekly feature, we share a variety of announcements covering funding, acquisitions, exits, grants, and everything in between. Got something to celebrate? Click here to share your story.

  • An Atlanta-based marketing technology company with a major presence in Indianapolis has closed on a $90 million Series C round of funding. Terminus, which acquired Indy-based Sigstr in late 2019, says the funding round will have a major impact on the company's central Indiana operations.
  • The National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) has awarded researchers at Washington University School of Medicine in St. Louis an eight-year, $8.8 million grant to study cells’ ion channels as potential targets for new drugs to treat disorders affecting the brain, heart and muscles.  
  • St. Louis-based venture capital firm Lagomaj Capital, which invests in early-stage startups, is building a plant science research and development facility with its portfolio company, Benson Hill.

  • After a two-year search, global IT and business consulting company CGI will invest $27 million to locate new operations in Knoxville, TN. The project is expected to create 300 jobs over the next five years.
  • Google is planning to open its first office in Minnesota as part of its ongoing health partnership with Rochester-based Mayo Clinic, according to a Star Tribune report.
  • Ag Startup Engine, located in the Iowa State University (ISU) Research Park, has announced an initial investment in two startups—Mazen Animal Health and Stockguard. Each startup will receive a $50,000 investment.

Share these stories!

Facebook Twitter
Alternate text

NAME THAT FLYOVER CITY!

It's time for our favorite trivia game!

 

Here are this week's questions:

  1. Arrowhead Stadium was the first stadium in professional football to bring High Dynamic Range (HDR) to its end zone display. In what city is it located?
  2. What city had a violent conflict over the construction of a bridge?
  3. In what city is the Bob Dylan archive located?

Click here for today's answers.

REACH OUT

Share stories, offer suggestions, or send comments!

CONTACT US

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • More
  • Print
  • Reddit
  • Tumblr
  • Pinterest
  • Pocket
  • Telegram
  • WhatsApp
  • Skype
Posted in Newsletters

Newsletters

  • Easing PPE demands | Vaccines and kids | Antiviral therapeutics April 14, 2021
  • Tech for horses | Podcast: Shared Lessons | Steve Case and the Rust Belt | Startup Funding April 8, 2021
  • Tech transfer during the pandemic | The growth of telehealth | HealthTech April 7, 2021
  • Indiana’s Life Sciences | Podcast: AI in Flyover Country | Autonomous car research April 1, 2021
  • A 5-minute COVID test | Aerosol science | HealthTech March 31, 2021

View All Newsletters

Podcasts

  • S2-E4: Focus on the Toaster: A Guide to Not Overthinking the Tech You Need April 5, 2021
  • S2-E3: Why AI implementation in Flyover Country is getting noticed March 29, 2021
  • S2-E2: State of Change: Inclusivity, Access, & Impact March 22, 2021
  • S2:E1 You can’t just say, “Because I said so” March 8, 2021
  • Innovators Podcast – S1 E12: Are you using the right data? February 1, 2021

View All Podcasts

Stories & Features

  • FUELING THE FUTURE: Minnesota growth, a new fund in Pittsburgh, $210M for a Madison unicorn April 15, 2021
  • PUDDLE HOPS: Arch Grants; IAM Robotics debuts Bolt; large-scale 3D printing April 15, 2021
  • Lewis & Clark Ventures brings funding to the Midwest April 15, 2021
  • Flyover HealthTech: Utilizing data, a quantum computer for Cleveland Clinic, & R&D April 14, 2021
  • Easing PPE demands | Vaccines and kids | Antiviral therapeutics April 14, 2021

View All Stories & Features

Our Network

Cincinnati Future

Indy Future

Louisville Future

More Cities on the way!

About Us

Mission and Team

Contact Us

© 2021 Flyover Future | Powered by MoDuet
Terms & Conditions | Privacy Policy